C8166Homo sapiens (Human)Transformed cell line

Also known as: C8166-CD4

🤖 AI SummaryBased on 5 publications

Quick Overview

Human T-cell leukemia cell line with HTLV-1 infection

Detailed Summary

The C8166 cell line is a human T-cell leukemia cell line derived from a patient with adult T-cell leukemia (ATL). It is known for its susceptibility to human T-cell leukemia virus type 1 (HTLV-1) infection and is widely used in research related to HTLV-1 pathogenesis and oncogenesis. This cell line exhibits characteristics of transformed T-cells, including uncontrolled proliferation and resistance to apoptosis. C8166 has been utilized in studies investigating the molecular mechanisms of HTLV-1-induced transformation, viral replication, and the role of the Tax protein in oncogenic processes. Additionally, it has been employed in the development of therapeutic strategies targeting HTLV-1-associated malignancies.

Research Applications

HTLV-1 infection and pathogenesisOncogenesis and tumor transformationViral replication and gene expressionTherapeutic target identification

Key Characteristics

HTLV-1 infectedTransformed T-cellsUncontrolled proliferationResistance to apoptosis
Generated on 6/16/2025

Basic Information

Database IDCVCL_1099
SpeciesHomo sapiens (Human)
Tissue SourceUmbilical cord blood[UBERON:UBERON_0012168]

Donor Information

0
Age CategoryFetus
SexMale

Disease Information

DiseaseT-Lymphoblastic Leukemia/Lymphoma
LineageLymphoid
SubtypeT-Lymphoblastic Leukemia/Lymphoma
OncoTree CodeTLL

DepMap Information

Source TypeSigma-Aldrich
Source IDACH-000206_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gln61Lys (c.181C>A)UnspecifiedAcquired during resistance selection processPubMed=26214590
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines.

Shimozato O., Taylor G.P., Bangham C.R.M., Derse D.D.

Blood 102:4130-4136(2003).

Restricted expression of human T-cell leukemia/lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Kalyanaraman V.S., Gallo R.C.

Virology 129:51-64(1983).

Web Resources